相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ambulatory Treatments for RAAS Inhibitor-Related Hyperkalemia and the 1-Year Risk of Recurrence
Gregory L. Hundemer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Clinical Management of Hyperkalemia
Biff F. Palmer et al.
MAYO CLINIC PROCEEDINGS (2021)
Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain
Antonio Olry de Labry Lima et al.
CLINICAL KIDNEY JOURNAL (2021)
Initial and Recurrent Hyperkalemia Events in Patients With CKD in Older Adults: A Population-Based Cohort Study
Sriram Sriperumbuduri et al.
CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE (2021)
Patiromer for Treatment of Hyperkalemia in the Emergency Department: A Pilot Study
Zubaid Rafique et al.
ACADEMIC EMERGENCY MEDICINE (2020)
Hyperkalemia in heart failure
Kiran Sidhu et al.
CURRENT OPINION IN CARDIOLOGY (2020)
Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind, Placebo-controlled Study (ENERGIZE)
W. Frank Peacock et al.
ACADEMIC EMERGENCY MEDICINE (2020)
Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate
Yao Qiao et al.
JAMA INTERNAL MEDICINE (2020)
Polysulfonate Resins in Hyperkalemia: A Systematic Review
Sheung Wing Sherwin Wong et al.
CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE (2020)
Derivation and Internal Validation of a Clinical Risk Prediction Tool for Hyperkalemia-Related Emergency Department Encounters Among Hemodialysis Patients
Paul E. Ronksley et al.
CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE (2020)
DASH Dietary Pattern and Cardiometabolic Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses
Laura Chiavaroli et al.
NUTRIENTS (2019)
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia A 12-Month Phase 3 Study
Bruce S. Spinowitz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Clinical Pharmacology in Diuretic Use
David H. Ellison
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
Steven Fishbane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients-A population-based cohort study
Kasper Adelborg et al.
PLOS ONE (2019)
Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
J. Ariana Noel et al.
JAMA INTERNAL MEDICINE (2019)
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal et al.
LANCET (2019)
Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
Cecilia Linde et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality
Joost C. Beusekamp et al.
JACC-HEART FAILURE (2019)
Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE
Simon D. Roger et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
Electrocardiographic manifestations of severe hyperkalemia
Laszlo Littmann et al.
JOURNAL OF ELECTROCARDIOLOGY (2018)
Revisiting RAAS blockade in CKD with newer potassium-binding drugs
Panagiotis I. Georgianos et al.
KIDNEY INTERNATIONAL (2018)
Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function
Adamasco Cupisti et al.
NUTRIENTS (2018)
Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes A Danish Population-Based Cohort Study
Reimar Wernich Thomsen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment
Anand Vaidya et al.
ENDOCRINE REVIEWS (2018)
Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system
Erik Nilsson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
How Dangerous Is Hyperkalemia?
John R. Montford et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia
Calvin J. Meaney et al.
PHARMACOTHERAPY (2017)
Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
Ghassan Bandak et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease
Michael V. Clausen et al.
FRONTIERS IN PHYSIOLOGY (2017)
Serum Potassium Levels and Risk of Sudden Cardiac Death Among Patients With Chronic Kidney Disease and Significant Coronary Artery Disease
Patrick H. Pun et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Race, Serum Potassium, and Associations With ESRD and Mortality
Yan Chen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Electrophysiology of Hypokalemia and Hyperkalemia
James N. Weiss et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)
Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function
Jiacong Luo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer
Murray Epstein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System
Alex R. Chang et al.
HYPERTENSION (2016)
Treatment of hyperkalemia: something old, something new
Richard H. Sterns et al.
KIDNEY INTERNATIONAL (2016)
Potassium Intake, Bioavailability, Hypertension, and Glucose Control
Michael S. Stone et al.
NUTRIENTS (2016)
Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management
Andre Gustavo P. Sousa et al.
WORLD JOURNAL OF DIABETES (2016)
Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD
Laurence Lepage et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease The AMETHYST-DN Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Matthew R. Weir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sodium Zirconium Cyclosilicate in Hyperkalemia
David K. Packham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Regulation of Potassium Homeostasis
Biff F. Palmer
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction
Maria Lukacs Krogager et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2015)
Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia The HARMONIZE Randomized Clinical Trial
Mikhail Kosiborod et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Characterization of Structure and Function of ZS-9, α K+ Selective Ion Trap
Fiona Stavros et al.
PLOS ONE (2014)
Gastrointestinal Adverse Events with Sodium Polystyrene Sulfonate (Kayexalate) Use: A Systematic Review
Ziv Harel et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Colonic necrosis due to calcium polystyrene sulfonate (Kalimate) not suspended in sorbitol
María Dolores Castillo-Cejas et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2013)
Secondary Prevention of Hyperkalemia With Sodium Polystyrene Sulfonate in Cardiac and Kidney Patients on Renin-Angiotensin-Aldosterone System Inhibition Therapy
Gil Chernin et al.
CLINICAL CARDIOLOGY (2012)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Severe hyperkalemia requiring hospitalization: predictors of mortality
Jung Nam An et al.
CRITICAL CARE (2012)
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2011)
Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study
Sonal Korgaonkar et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Ion-Exchange Resins for the Treatment of Hyperkalemia: Are They Safe and Effective?
Richard H. Sterns et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive Therapy
Joy M. Weinberg et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Colonic Mucosal Necrosis Following Administration of Calcium Polystryrene Sulfonate (Kalimate) in a Uremic Patient
Mee Joo et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Uzma F. Mehdi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
S. Bianchi et al.
KIDNEY INTERNATIONAL (2006)
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
Anastasia Chrysostomou et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Rates of hyperkalemia after publication of the randomized aldactone evaluation study
DN Juurlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
BF Palmer
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
MA Pfeffer et al.
LANCET (2003)
分享论文
